Jamie Studts, PhD, has co-created a project designed to boost lung cancer screening rates in Kentucky earning a grant from the Bristol Myers Squibb Foundation.
Dr. Laura Graham, is currently leading a phase 2 trial studying whether high doses of testosterone are a feasible treatment against castration-resistant prostate cancer (CRPC) leading to a reduction in prostate cancer growth as well as improved quality of life.